Pliant Therapeutics Ownership | Who Owns Pliant Therapeutics?

Pliant Therapeutics Ownership Summary

Pliant Therapeutics is owned by 17.33% institutional investors, 2.35% insiders, and 80.32% retail investors. Tang capital management is the largest institutional shareholder, holding 10.01% of PLRX shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 3.84% of its assets in Pliant Therapeutics shares.

PLRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pliant Therapeutics	17.33%	2.35%	80.32%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tang capital management	6.14M	10.01%	$7.74M
Blackrock	4.97M	8.26%	$53.45M
Citadel advisors	3.23M	5.26%	$4.07M
Blue owl capital lp	2.97M	4.84%	$3.74M
Vanguard group	2.82M	4.59%	$3.44M
Acadian asset management	2.42M	3.94%	$3.04M
Two sigma investments, lp	2.25M	3.67%	$2.84M
Monaco asset management sam	1.94M	3.16%	$2.44M
Renaissance	1.85M	3.02%	$2.33M
Prosight management, lp	1.67M	2.72%	$2.10M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Mass general brigham	288.69K	15.11%	$3.10M
Fernwood investment management	425.42K	1.95%	$5.60M
Peapod lane capital	1.29M	1.30%	$1.59M
Bml capital management	1.55M	1.25%	$1.95M
Blue owl capital lp	2.97M	1.01%	$3.74M
Great point partners	850.00K	0.52%	$1.26M
Monaco asset management sam	1.94M	0.45%	$2.44M
Tang capital management	6.14M	0.39%	$7.74M
Prosight management, lp	1.67M	0.34%	$2.10M
Nano cap new millennium growth fund l p	275.00K	0.32%	$346.50K

Top Buyers

Holder	Shares	% Assets	Change
Two sigma investments, lp	2.25M	0.00%	1.30M
Renaissance	1.85M	0.00%	807.02K
Millennium management	1.18M	0.00%	771.69K
Citadel advisors	3.23M	0.00%	643.27K
Two sigma advisers, lp	1.07M	0.00%	617.30K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-3.95M
Paradigm biocapital advisors lp	-	-	-3.20M
Cormorant asset management, lp	-	-	-3.00M
Madison avenue partners, lp	-	-	-2.23M
Trv gp iv	-	-	-2.13M

New Positions

Holder	Shares	% Assets	Change	Value
Dafna capital management	487.00K	0.14%	487.00K	$613.62K
Vanguard fiduciary trust	339.54K	0.00%	339.54K	$427.82K
Verdad advisers, lp	98.32K	0.14%	98.32K	$123.88K
Ameriprise financial	55.13K	-	55.13K	$69.46K
Public employees retirement system of ohio	28.50K	0.00%	28.50K	$35.91K

Sold Out

Holder	Change
Allworth financial lp	-2.00
Mine & arao wealth creation & management, llc.	-2.00
National bank of canada /fi/	-8.00
Nelson, van denburg & campbell wealth management group	-11.00
Raymond james financial	-12.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	25	-74.75%	10,633,375	-77.23%	17	0.30%	11	-75.56%	5	-83.87%
Dec 31, 2025	56	-44.55%	26,887,844	-46.66%	43	0.65%	22	-35.29%	18	-57.14%
Sep 30, 2025	51	-56.03%	19,820,683	-61.51%	32	0.46%	17	-67.31%	22	-45.00%
Jun 30, 2025	115	-18.44%	51,469,896	-10.18%	83	0.96%	51	-31.08%	40	2.56%
Mar 31, 2025	142	-13.41%	57,894,025	-10.59%	94	0.83%	75	-5.06%	39	-4.88%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	2.34M	3.84%	-75.06K
T. Rowe Price New Horizons	2.34M	3.82%	-676.00
DWS ESG Akkumula LC	2.30M	3.76%	-4.00
Vanguard US Total Market Shares ETF	2.03M	3.32%	-
Polar Capital Biotech S Inc	1.85M	3.02%	-
Fidelity Growth Compy Commingled Pl S	1.82M	2.96%	-
Fidelity Growth Compy Commingled Pl O	1.77M	2.91%	-
Vanguard Total Stock Mkt Idx Inv	1.75M	2.82%	-
Fidelity Growth Company Fund	1.29M	2.11%	-2.64K
Candriam Eqs L Biotech C USD Cap	900.10K	1.47%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 20, 2026	Cummings Keith Lamont	Chief Financial Officer	Sell	$30.72K
Jan 20, 2026	Cheung Lily	Chief Human Resource Officer	Sell	$9.64K
Jan 20, 2026	Coulie Bernard	President and CEO	Sell	$114.40K
Jan 20, 2026	Kuo Minnie	Chief Operating Officer	Sell	$8.85K
Jan 17, 2025	Coulie Bernard	President and CEO	Sell	$587.15K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	4
2025 Q4	-	-
2025 Q2	-	-
2025 Q1	-	7

PLRX Ownership FAQ

Who Owns Pliant Therapeutics?

Pliant Therapeutics shareholders are primarily institutional investors at 17.33%, followed by 2.35% insiders and 80.32% retail investors. The average institutional ownership in Pliant Therapeutics's industry, Biotech Stocks , is 35.75%, which Pliant Therapeutics falls below.

Who owns the most shares of Pliant Therapeutics?

Pliant Therapeutics’s largest shareholders are Tang capital management (6.14M shares, 10.01%), Blackrock (4.97M shares, 8.26%), and Citadel advisors (3.23M shares, 5.26%). Together, they hold 23.53% of Pliant Therapeutics’s total shares outstanding.

Does Blackrock own Pliant Therapeutics?

Yes, BlackRock owns 8.26% of Pliant Therapeutics, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 53.45M$. In the last quarter, BlackRock increased its holdings by 316.25K shares, a 6.79% change.

Who is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested?

Mass general brigham is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.11% of its assets in 288.69K Pliant Therapeutics shares, valued at 3.1M$.

Who is the top mutual fund holder of Pliant Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Pliant Therapeutics shares, with 3.84% of its total shares outstanding invested in 2.34M Pliant Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools